NCT06508034View on ClinicalTrials.gov

Probiotics for the Prevention of Immunotherapy Induced Colitis in Patients Receiving Immunotherapy

NARecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2024

Primary Completion Date

August 30, 2027

Study Completion Date

August 30, 2027

Conditions
Malignant Solid Neoplasm
Interventions
PROCEDURE

Biospecimen Collection

Undergo stool and blood sample collection

DIETARY_SUPPLEMENT

Live Freeze-Dried Lactic Acid Bacteria Probiotic

Given PO

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

32224-9980

RECRUITING

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT06508034 - Probiotics for the Prevention of Immunotherapy Induced Colitis in Patients Receiving Immunotherapy | Biotech Hunter | Biotech Hunter